Crossref
Survival analysis of HER2-low versus HER2-zero breast cancer patients after postoperative radiotherapy: a real-world retrospective study
American Journal of Cancer Research · 2026 · 16 (10) · 4433-4449
DOI: 10.62347/ttxs8134 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yuan Zhang und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, Y., Xiang, C., & Wu, D. (2026). Survival analysis of HER2-low versus HER2-zero breast cancer patients after postoperative radiotherapy: a real-world retrospective study. American Journal of Cancer Research, 16(10), 4433-4449. https://doi.org/10.62347/ttxs8134
Vancouver
Zhang Y, Xiang C, Wu D. Survival analysis of HER2-low versus HER2-zero breast cancer patients after postoperative radiotherapy: a real-world retrospective study. American Journal of Cancer Research. 2026;16(10):4433-4449. doi:10.62347/ttxs8134
BibTeX
@article{Zhang2026,
author = {Zhang, Yuan and Xiang, Chengcheng and Wu, Danxin},
title = {Survival analysis of HER2-low versus HER2-zero breast cancer patients after postoperative radiotherapy: a real-world retrospective study},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4433--4449},
doi = {10.62347/ttxs8134}
}
EUVIMED